Skip to main content
. 2008 Jun 24;99(2):371–374. doi: 10.1038/sj.bjc.6604453

Table 2. All cause mortality in BRCA2 vs BRCA1 patients with prostate cancer.

  Univariate
Age-adjusted
  HR (95% CI) P HR (95% CI) P
BRCA2 vs BRCA1 All subjects 1.64 (1.17–2.30) 0.005 1.71 (1.22–2.41) 0.002
BRCA2 vs BRCA1 Known carriers 2.41 (1.28–4.52) 0.006 2.48 (1.31–4.70) 0.005

Hazard ratio represents mortality experience of patients with BRCA2 mutations compared to those with BRCA1 mutations, calculated using Cox proportional hazards model.